Aurobindo Pharma
BSE: 524804
|
NSE: AUROPHARMA
Aurobindo Pharma
(CIN: L24239TG1986PLC015190)
operates in the Pharmaceuticals industry and has been listed in the stock market since 6th Apr 1995.
It currents trades on NSE with symbol AUROPHARMA and on BSE with scrip code 524804.
The registered office of the company is Plot No.2, Maitrivihar, Ameerpet,Hyderabad,Telangana,500038.
The management team of Aurobindo Pharma is led by Mr. K.Ragunathan who is the Non-Executive - Independent Director-Chairperson. Other members of the management team consist of Santhanam Subramanian (Designation:Chief Financial Officer), Mr. K.Nithyananda Reddy (Designation:Executive Director), Mr. N. Govindarajan (Designation:Executive Director-MD), Mr. M.Sivakumaran (Designation:Executive Director), Mr. M Madan Mohan Reddy (Designation:Executive Director), Mr. P V Ramprasad Reddy (Designation:Non-Executive - Non Independent Director), Mr. M Sitarama Murty (Designation:Non-Executive - Independent Director), Mr. P Sarath Chandra Reddy (Designation:Executive Director), Mrs. Dr Avnit Bimal Singh (Designation:Non-Executive - Independent Director), Mrs. Savita Mahajan (Designation:Non-Executive - Independent Director), B Adi Reddy (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Aurobindo Pharma is as below -
The registered office of the company is Plot No.2, Maitrivihar, Ameerpet,Hyderabad,Telangana,500038.
The management team of Aurobindo Pharma is led by Mr. K.Ragunathan who is the Non-Executive - Independent Director-Chairperson. Other members of the management team consist of Santhanam Subramanian (Designation:Chief Financial Officer), Mr. K.Nithyananda Reddy (Designation:Executive Director), Mr. N. Govindarajan (Designation:Executive Director-MD), Mr. M.Sivakumaran (Designation:Executive Director), Mr. M Madan Mohan Reddy (Designation:Executive Director), Mr. P V Ramprasad Reddy (Designation:Non-Executive - Non Independent Director), Mr. M Sitarama Murty (Designation:Non-Executive - Independent Director), Mr. P Sarath Chandra Reddy (Designation:Executive Director), Mrs. Dr Avnit Bimal Singh (Designation:Non-Executive - Independent Director), Mrs. Savita Mahajan (Designation:Non-Executive - Independent Director), B Adi Reddy (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Aurobindo Pharma is as below -
Volume: 2,01,795.00
M. Cap: 46,673.00
P/E: 20.68
Prev. Close: 796.55
Day
52 Wk
Symbol is not Traded Today for NSE
Stock Price Chart
F&O Data
| Expiry Date | Open Price | High Price | Low Price | Prev Close | Last Price | Volume | Turnover Lacs | Underlying Value |
|---|---|---|---|---|---|---|---|---|
| 29-10-2020 | 799.85 | 824.75 | 797.80 | 799.40 | 806.40 | 5,884.00 | 62,157.40 | 802.45 |
| 26-11-2020 | 801.30 | 826.50 | 801.30 | 801.95 | 809.05 | 69.00 | 729.70 | 802.45 |
| 31-12-2020 | 819.60 | 820.90 | 818.50 | 809.50 | 818.50 | 3.00 | 31.97 | 802.45 |
| Calls | 29 Oct 2020 | Puts | ||||||
|---|---|---|---|---|---|---|---|---|
| OI (Delta OI) |
LTP (Change) |
Intrinsic Value | Time Value | Strike Price | Time Value | Intrinsic Value | LTP (Change) |
OI (Delta OI) |
| - |
- |
- | - | 500 | - | - | - |
- |
| - |
- |
- | - | 520 | - | - | - |
- |
| - |
- |
- | - | 540 | - | - | - |
- |
| - |
- |
- | - | 560 | - | 0 | - |
1,300 (-) |
| - |
- |
- | - | 580 | - | - | - |
- |
| - |
- |
- | - | 600 | 0.95 | 0 | 0.95 (-) |
91,000 (-2,600.00) |
| - |
- |
- | - | 620 | - | - | - |
- |
| - |
- |
- | - | 640 | - | - | - |
- |
| 1,300 (-) |
- |
136.6 | - | 660 | 2.25 | 0 | 2.25 (+0.30) |
13,000 (+1,300.00) |
| - |
- |
- | - | 680 | 3.65 | 0 | 3.65 (+0.20) |
88,400 (-5,200.00) |
| 2,600 (-) |
- |
96.6 | - | 700 | 5.8 | 0 | 5.80 (+0.15) |
2,61,300 (+6,500.00) |
| - |
- |
- | - | 720 | 8.4 | 0 | 8.40 (-0.75) |
3,41,900 (-11,700.00) |
| 44,200 (+1,300.00) |
80.00 (+6.00) |
56.6 | 23.4 | 740 | 12.6 | 0 | 12.60 (-1.20) |
1,98,900 (+9,100.00) |
| 1,61,200 (-14,300.00) |
62.90 (+2.95) |
36.6 | 26.3 | 760 | 18.4 | 0 | 18.40 (-1.55) |
2,10,600 (-6,500.00) |
| 1,28,700 (-5,200.00) |
52.05 (+4.75) |
16.6 | 35.45 | 780 | 26.25 | 0 | 26.25 (-1.90) |
2,41,800 (+13,000.00) |
| 5,99,300 (-1,19,600.00) |
41.10 (+3.65) |
0 | 41.1 | 800 | 31.9 | 3.4 | 35.30 (-2.55) |
3,21,100 (-14,300.00) |
| 4,75,800 (+1,15,700.00) |
31.50 (+2.60) |
0 | 31.5 | 820 | 22.05 | 23.4 | 45.45 (-6.90) |
85,800 (+16,900.00) |
| 3,77,000 (+28,600.00) |
24.00 (+1.95) |
0 | 24 | 840 | 13.6 | 43.4 | 57.00 (-18.55) |
1,06,600 (-) |
| 3,09,400 (+15,600.00) |
19.25 (+2.50) |
0 | 19.25 | 860 | 6.6 | 63.4 | 70.00 (-14.40) |
16,900 (-) |
| 1,71,600 (-1,300.00) |
13.85 (+1.00) |
0 | 13.85 | 880 | - | 83.4 | - |
2,600 (-) |
| 5,39,500 (-7,800.00) |
10.45 (+0.60) |
0 | 10.45 | 900 | 4.3 | 103.4 | 107.70 (-1.05) |
11,700 (-1,300.00) |
| 91,000 (+5,200.00) |
8.40 (+0.95) |
0 | 8.4 | 920 | - | 123.4 | - |
2,600 (-) |
| 39,000 (+3,900.00) |
6.05 (+0.55) |
0 | 6.05 | 940 | - | 143.4 | - |
2,600 (-) |
| 31,200 (+11,700.00) |
5.00 (+0.90) |
0 | 5 | 960 | - | 163.4 | - |
1,300 (-) |
| - |
- |
- | - | 980 | - | - | - |
- |
| 3,77,000 (+22,100.00) |
3.35 (+0.45) |
0 | 3.35 | 1,000 | - | - | - |
- |
| 10,400 (-) |
2.95 (+1.30) |
0 | 2.95 | 1,020 | - | - | - |
- |
| 3,900 (-) |
3.00 (+1.45) |
0 | 3 | 1,040 | - | - | - |
- |
| - |
- |
- | - | 1,060 | - | - | - |
- |
| - |
- |
- | - | 1,080 | - | - | - |
- |
| 1,300 (-) |
- |
0 | - | 1,100 | - | - | - |
- |
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 28,67,65,471 | 48.94 |
| Foreign Institutions | 13,25,73,949 | 22.63 |
| NBFC and Mutual Funds | 7,15,00,458 | 12.20 |
| Others | 2,63,77,719 | 4.50 |
| General Public | 4,86,00,880 | 8.29 |
| Financial Institutions | 21,20,132 | 0.36 |
| ForeignPromoter | 1,80,00,000 | 3.07 |
| Total | 58,59,38,609 | 99.99 |
Financial Data
Consolidated
| Figures in crore | 2020 | 2019 | 2018 |
|---|---|---|---|
| Net Sales | 23,098.51 | 19,563.55 | 16,463.03 |
| Operating Profit | 5,014.88 | 4,021.90 | 3,876.87 |
| Other Income | 191.87 | 158.02 | 105.12 |
| Interest | 305.13 | 262.60 | 77.72 |
| Depreciation | 966.71 | 667.95 | 557.97 |
| Profit Before Tax | 3,743.04 | 3,091.35 | 3,241.18 |
| Tax | 913.52 | 726.85 | 818.27 |
| Profit After Tax | 2,829.52 | 2,364.50 | 2,422.91 |
| Share Capital | 58.59 | 58.59 | 58.59 |
| Reserves | 16,751.79 | 13,832.19 | 11,621.83 |
| Net Worth | 16,810.38 | 13,890.78 | 11,680.42 |
| Loans | 5,988.57 | 7,046.92 | 4,836.36 |
| Gross Block | 12,441.26 | 10,497.62 | 7,894.78 |
| Investments | 554.71 | 360.22 | 311.54 |
| Cash | 2,842.15 | 1,957.18 | 1,262.25 |
| Debtors | 4,315.15 | 3,413.78 | 3,080.20 |
| Net Working Capital | 10,861.97 | 10,435.76 | 8,103.34 |
| Operating Profit Margin (%) | 21.71 | 20.56 | 23.55 |
| Net Profit Margin (%) | 12.25 | 12.09 | 14.72 |
| Earning Per Share (Rs) | 48.32 | 40.36 | 41.36 |
| Dividend (%) | 300.00 | 250.00 | 250.00 |
| Dividend Payout | 175.78 | 146.48 | 219.71 |
Standalone
| Figures in crore | 2020 | 2019 | 2018 |
|---|---|---|---|
| Net Sales | 13,266.48 | 12,257.89 | 10,269.90 |
| Operating Profit | 3,089.12 | 2,608.51 | 2,750.66 |
| Other Income | 403.37 | 199.22 | 80.65 |
| Interest | 240.94 | 230.86 | 52.89 |
| Depreciation | 470.48 | 413.03 | 354.83 |
| Profit Before Tax | 2,377.70 | 1,964.62 | 2,342.94 |
| Tax | 504.96 | 434.89 | 530.17 |
| Profit After Tax | 1,872.74 | 1,529.73 | 1,812.77 |
| Share Capital | 58.59 | 58.59 | 58.59 |
| Reserves | 12,966.97 | 11,292.03 | 9,923.99 |
| Net Worth | 13,025.56 | 11,350.62 | 9,982.58 |
| Loans | 3,783.90 | 4,542.44 | 3,752.60 |
| Gross Block | 6,115.18 | 5,446.15 | 4,292.18 |
| Investments | 2,519.70 | 2,339.06 | 1,967.50 |
| Cash | 78.25 | 75.77 | 245.90 |
| Debtors | 5,789.57 | 5,232.07 | 4,468.23 |
| Net Working Capital | 9,198.45 | 8,615.29 | 7,230.73 |
| Operating Profit Margin (%) | 23.29 | 21.28 | 26.78 |
| Net Profit Margin (%) | 14.12 | 12.48 | 17.65 |
| Earning Per Share (Rs) | 31.96 | 26.11 | 30.94 |
| Dividend (%) | 300.00 | 250.00 | 250.00 |
| Dividend Payout | 175.78 | 146.48 | 219.71 |
| Bonus History | Date | Ratio |
|---|---|
| 20 Jul 2015 | issue 1:1 |
Financial Data Graph
The peers of Aurobindo Pharma are DRREDDY, CIPLA and SUNPHARMA*. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.